Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Novo Nordisk and Zoetis are poised for long-term success with their focus on obesity drugs and animal health. Both offer affordable entry points and growing dividends, making them attractive to smart investors.